Regional Citrate Anticoagulation during Double-Filtration Plasmapheresis in Kidney Transplant Recipients: A Single-Center Retrospective Cohort Study

Conclusion: Protocol-based RCA for DFPP is feasible and safe in KTx recipients. However, DFPP-related coagulopathy can develop consequent to treatment; caution should be exercised for patients with bleeding risk. Close monitoring and management of the patients ’ electrolytes, especially hypocalcemia and hypomagnesemia, and fluid status is recommended.Blood Purif
Source: Blood Purification - Category: Hematology Source Type: research